When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Gilead Sciences (NASDAQ:GILD) licensee Mylan N.V. (NASDAQ:MYL) announces that the Drug Controller General of India has approved its remdesivir 100 mg/vial for restricted emergency use for severely ill hospitalized pediatric and adult COVID-19 patients.
More news on: Mylan, Inc., Gilead Sciences, Inc., Healthcare stocks news, Stocks on the move,